InBody Co. Ltd. | Mutual Funds

Mutual Funds that own InBody Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
527,392
3.85%
90,052
0%
12/31/2017
Candriam Equities L - Emerging Markets
200,000
1.46%
-150,000
0.32%
07/31/2018
Vanguard Total International Stock Index Fund
141,210
1.03%
0
0%
07/31/2018
Mirae Asset TIGER China Consumer
128,425
0.94%
-22,828
1.47%
04/30/2018
iShares Core MSCI Emerging Markets ETF
125,645
0.92%
0
0.01%
09/05/2018
DFA Emerging Markets Small Cap Series
93,707
0.69%
0
0.03%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
81,770
0.6%
-6,640
0.01%
04/30/2018
MainStay VP Emerging Markets Equity Portfolio.
70,567
0.52%
-8,155
0.33%
05/31/2018
Vanguard Developed Markets Index Fund
59,060
0.43%
0
0%
07/31/2018
British Columbia Inv Management Corp.
38,423
0.28%
38,423
0%
03/31/2017

About InBody Co.

View Profile
Address
InBody Building
Seoul SL 06313
Korea, Republic Of
Employees -
Website http://www.inbody.com
Updated 09/14/2018
InBody Co., Ltd. engages in the manufacture and sale of medical equipment. Its products include body composition analyzers, automatic shpygmomanometers, and extensometers. The company was founded by Cha Ki-Chul on May 15, 1996 and is headquartered in Seoul, South Korea.